Abstract
Survival analysis in patients with pulmonary metastatic renal cell carcinoma (MRCC) treated by inhaled interleukin-2 (IL-2) compared to prognostic stratification models
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have